Results 51 to 60 of about 711,937 (246)

Rituximab-Associated Inflammatory Progressive Multifocal Leukoencephalopathy

Case Reports in Infectious Diseases, 2016
Progressive multifocal leukoencephalopathy (PML) is a rare disease of the immunosuppression that results from neurotropic invasion of the JC virus which leads to demyelination of oligodendrocytes.
Chandra Punch, Christina Schofield, Penelope Harris   +2 more
doaj   +1 more source

Myoclonus as an unusual presentation of progressive multifocal leukoencephalopathy in a HIV positive patient [PDF]

Romanian Journal of Neurology, 2012
From mild muscular contractions to gross jerks affecting the whole body, myoclonus is an involuntary movement caused by an excessive discharge from a group of neurons located in one or multiple sites from cortical to peripheral level.
Lucian Chicea, Elena Cecilia Rosca, Ovidiu Rosca, M. Ciolan, Mihaela Simu   +4 more
doaj   +1 more source

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy [PDF]

, 2006
Background: Progressive multifocal leukoencephalopathy (PML) was reported to have developed in three patients treated with natalizumab. We conducted an evaluation to determine whether PML had developed in any other treated patients.
Major, E.O., Clifford, D.B., Habil, M., Fischer, S., Barkhof, F., Yousry, T.A., Hou, J., Radue, E.-W., Ryschkewitsch, C., Mueller-Lenke, N., Jäger, H.R., Sanchez, E., Curfman, B., Miszkiel, K., Fahle, G.   +14 more
core  

Does Mefloquine (Lariam®) Therapy Improve the Prognosis of Human JC Polyomavirus-Induced Progressive Multifocal Leukoencephalopathy? [PDF]

Journal of Biomedical & Clinical Research, 2014
Progressive multifocal leukoencephalopathy (PML) is ademyelinating disease caused by infection with Polyomavirus hominis 2, popularly known as JC virus (JCV).
Zlatko Kalvatchev, Iliya Tsekov
doaj   +3 more sources

Evaluating discrepancies between high‐yield neuroscience conditions in preclerkship medical education and national clinical incidence

Anatomical Sciences Education, EarlyView.
Abstract Medical education must balance foundational science with clinical relevance. Increasing emphasis on standardized assessments has led to prioritization of “high‐yield” conditions—those most likely to be assessed. Subsequently, educators and students often prioritize these conditions.
Kathryn Veazey, Oheneba Boadum
wiley   +1 more source

Concurrent progressive multifocal leukoencephalopathy and central nervous system infiltration by multiple myeloma: A case report

, 2018
Progressive multifocal leukoencephalopathy rarely occurs in patients with multiple myeloma. Intracranial central nervous system invasion is also an uncommon event in multiple myeloma, occurring in less than 1% of cases. We describe herein an exceptional
Yanira Ruiz-Heredia, Hernández Laín, Aurelio, Inmaculada Rapado, Luis Collado, Santiago Barrio, Keith Stewart, Ruiz Heredia, Yanira, Joaquin Martinez-Lopez, Juan Ruiz, Oscar Toldos, Linares Gómez, María, Braggio, Esteban, Esteban Braggio, Aurelio Hernandez-Lain, Rapado, Inmaculada, Toldos González, Óscar, Collado Yurrita, Luis Rodolfo, Ana Ramos, Stewart, Keith, María Linares, Sánchez Vega, Beatriz, Martínez López, Joaquín, Ruiz Albusac, Juan Miguel, M Dolores Folgueira, Beatriz Sanchez-Vega, Ramos González, Ana, Barrio, Santiago, Folgueira López, María Dolores   +27 more
core   +1 more source

Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab

Neurology: Neuroimmunology & Neuroinflammation, 2020
Objective To describe the disease course of carryover progressive multifocal leukoencephalopathy (PML) after switching from natalizumab to ocrelizumab in 2 patients with relapsing-remitting MS.
Alyssa A. Toorop, Z. V. van Lierop, E. Strijbis, C. Teunissen, A. Petzold, M. Wattjes, F. Barkhof, B. D. de Jong, Z. V. van Kempen, J. Killestein   +9 more
semanticscholar   +1 more source

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

British Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

A Case of Progressive Multifocal Leucoencephalopathy and Cerebral Toxoplasmosis in an HIV-Infected Patient

Acta Medica Bulgarica, 2023
Progressive multifocal leukoencephalopathy (PML) is an opportunistic infection of the central nervous system (CNS) caused by the reactivation of John Cunningham polyomavirus (JCV).
Yancheva-Petrova N., Grozdeva R., Nikolova M., Aleksiev I., Rainova I., Tsvetkova N., Strashimirov D.   +6 more
doaj   +1 more source

Course of neuropsychological impairment during Natalizumab associated progressive multifocal leukoencephalopathy. [PDF]

, 2021
BACKGROUND Progressive multifocal leukoencephalopathy (PML) - an opportunistic infection of the central nervous system with the John Cunningham virus (JCV) - is a side-effect of Natalizumab (NTZ) treatment for relapsing remitting (RR) multiple ...
Kinner, M, Andew Chan, Ralf Gold, Hoepner, R, Christoph Schroeder, Christian Prehn, Ruth Schneider, Kolb, E, Robert Hoepner, Prehn, C, Markus Kinner, Schneider, R, Schroeder, C, Eva Kolb, Chan, A, Gold, R   +15 more
core   +3 more sources